ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

“Tone” Of Statement Lacks Balance, Klausner Says

January 31, 1997

In Brief: White House Conservative Said Seeking Ouster Of Schweiker; Potter urges Greater Commitment

November 26, 1982

New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division

July 25, 1980

As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal

February 3, 1995